Interactive Financial Advisors Exits Position in Baxter International Inc (BAX)

Baxter International Inc (BAX) : Interactive Financial Advisors has sold out all of its stake in Baxter International Inc during the most recent quarter, according to the disclosure filed by the company on Jul 14, 2016 with the SEC. The investment management company has sold out 16 shares of Baxter International Inc which is valued at $745.

Other Hedge Funds, Including , Lodestar Investment Counselil reduced its stake in BAX by selling 3,700 shares or 17.83% in the most recent quarter. The Hedge Fund company now holds 17,054 shares of BAX which is valued at $793,864. Baxter International Inc makes up approx 0.11% of Lodestar Investment Counselil’s portfolio.Bkd Wealth Advisors reduced its stake in BAX by selling 1,550 shares or 5.38% in the most recent quarter. The Hedge Fund company now holds 27,273 shares of BAX which is valued at $1,276,922. Baxter International Inc makes up approx 0.19% of Bkd Wealth Advisors’s portfolio.Davenport Co reduced its stake in BAX by selling 8,372 shares or 45.91% in the most recent quarter. The Hedge Fund company now holds 9,862 shares of BAX which is valued at $461,739. Baxter International Inc makes up approx 0.01% of Davenport Co’s portfolio.Triangle Securities Wealth Management reduced its stake in BAX by selling 3,910 shares or 23.48% in the most recent quarter. The Hedge Fund company now holds 12,745 shares of BAX which is valued at $594,554. Baxter International Inc makes up approx 0.44% of Triangle Securities Wealth Management’s portfolio.Cohen Lawrence B reduced its stake in BAX by selling 1,850 shares or 22.77% in the most recent quarter. The Hedge Fund company now holds 6,275 shares of BAX which is valued at $292,729. Baxter International Inc makes up approx 0.17% of Cohen Lawrence B’s portfolio.

Baxter International Inc closed down -0.22 points or -0.47% at $46.55 with 28,11,905 shares getting traded on Monday. Post opening the session at $46.81, the shares hit an intraday low of $46.34 and an intraday high of $46.86 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Baxter International Inc reported $0.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.29. The company had revenue of $2375.00 million for the quarter, compared to analysts expectations of $2351.22 million. The company’s revenue was down -1.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Baxter International Inc. Baxter International Inc was Resumed by JP Morgan to “Neutral” on Jun 6, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 47 from a previous price target of $40 .

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *